San Antonio Breast Cancer Symposium 2023

San Antonio Breast Cancer Symposium 2023
December 05-09, 2023
San Antonio, TX

San Antonio Breast Cancer Symposium 2023.

Explore more information for Gilead Oncology therapies
Results (4)

ASCENT-07 A Phase 3, Randomized, Open-Label Study of Sacituzumab Govitecan Versus Treatment of Physician’s Choice in Patients with HR+HER2– Inoperable, Locally Advanced, or Metastatic Breast Cancer Post-Endocrine Therapy

Overall survival results from EVER-132-001, a phase 2b single-arm study of sacituzumab govitecan in Chinese patients with metastatic triple-negative breast cancer

Exposure-response analyses of sacituzumab govitecan efficacy and safety in patients with metastatic breast cancer

Coming Soon!